Improving recovery after surgery for extremity sarcoma
Enhanced Recovery After Surgery in Extremity Sarcoma
This study is testing a new recovery plan for people having surgery for extremity sarcoma to see if it helps them manage pain better and recover faster without using narcotics.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Vanderbilt-Ingram Cancer Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Trial ID | NCT04461171 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of an enhanced recovery after surgery (ERAS) pathway for patients undergoing surgical treatment for extremity sarcoma. It focuses on implementing a non-narcotic, multimodal pain management approach during the perioperative period. Key outcomes will include patient-reported pain scores, limb function assessments, and clinical metrics such as hospital length of stay and opioid usage. The study will collect data on these endpoints to determine the overall impact of the ERAS protocol on recovery.
Who should consider this trial
Good fit: Ideal candidates include adult patients over 17 years old who are undergoing surgical excision for suspected extremity sarcoma at Vanderbilt University Medical Center.
Not a fit: Patients who are treated non-operatively or are non-English speaking may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery experiences and outcomes for patients undergoing surgery for extremity sarcoma.
How similar studies have performed: Other studies have shown success with enhanced recovery protocols in various surgical contexts, suggesting potential for positive outcomes in this setting as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient at Vanderbilt University Medical Center treated with surgical excision of a suspected extremity sarcoma * Adult patients \>17 years of age * Patients of all preoperative opioid status (naïve or dependent) Exclusion Criteria: * Patients treated non-operatively * Non-English speaking patients
Where this trial is running
Nashville, Tennessee
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (Recruiting)
Study contacts
- Principal investigator: Joshua Lawrenz, MD — Vanderbilt Medical Center
- Study coordinator: Vanderbilt-Ingram Service for Timely Access
- Email: cip@vumc.org
- Phone: 800-811-8480
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.